Avandia, manufactured by GlaxoSmithKline PLC, is prescribed to treat Type 2 diabetes. It works to increase the body’s sensitivity to insulin. On May 25, 1999, Avandia was approved by the U.S. Food and Drug Administration. Since then, it has been prescribed to over 6 million patients.
As a result of 42 randomized clinical trials, researchers discovered that Avandia may raise the risk of cardiac events by 30 to 40 percent. Overall, Avandia clinical studies indicate that the medication increases the risk of bone fractures and adverse cardiovascular events, such as congestive heart failure and heart attacks.
If you or someone you know is taking Avandia, it is very important to be aware of the below symptoms of congestive heart failure:
Reportedly, GlaxoSmithKline PLC, the manufacturer of Avandia, did not warn patients of the potential risks associated with Avandia. The FDA has recommended that GlaxoSmithKline PLC include a blackbox warning on the label of Avandia in order to warn patients of the risks.
You may be at risk for a serious cardiac event if you have been prescribed Avandia. It is very important to contact a Avandia attorney at McDonald, Rothweiler and Eisenberg who will be able to determine if you have a case. Contact our Avandia heart attack attorneys for a free consultation.
